LeadIQ logo
Learn more at LeadIQ.com

Insights

Award Recognition Ultragenyx has received multiple prestigious awards, including the 2024 Top Workplaces Culture Excellence award and the MassEcon Gold Award for Economic Impact. This recognition not only enhances the company's reputation but also opens doors for potential sales opportunities through increased visibility and credibility.

Public Offering The company recently went public and announced a proposed public offering of common stock. This move indicates potential growth and expansion opportunities, presenting a chance for sales professionals to engage with investors and stakeholders interested in the biopharmaceutical sector.

Corporate Responsibility Ultragenyx published its 2023 Corporate Responsibility Report, highlighting its commitment to transforming the lives of individuals affected by rare diseases. Such transparency and social responsibility efforts can attract socially conscious partners and investors, creating avenues for sales collaborations.

Investment Influx Sandia Investment Management LP recently invested $308,000 into Ultragenyx Pharmaceutical Inc. This infusion of capital signifies investor confidence in the company's growth potential, presenting opportunities for sales representatives to leverage this vote of confidence in their pitches to potential clients.

Diverse Product Portfolio Ultragenyx boasts a diverse portfolio of approved therapies for rare genetic diseases with high unmet medical needs. Sales professionals can leverage the unique value proposition of the company's innovative medicines to target healthcare providers, institutions, and patient advocacy groups seeking cutting-edge treatment solutions.

Similar companies to Ultragenyx

Ultragenyx Tech Stack

Ultragenyx uses 8 technology products and services including Atlassian, Power BI, AutoCad, and more. Explore Ultragenyx's tech stack below.

  • Atlassian
    Application Development & Management
  • Power BI
    Business Intelligence
  • AutoCad
    Cad & Graphics
  • Unpkg
    Content Delivery Network
  • Font Awesome
    Font Scripts
  • Willis Towers Watson
    Human Resource Management System
  • Juniper Networks
    IT Infrastructure & Operations Management
  • Windows Server
    Operating Systems

Media & News

Ultragenyx's Email Address Formats

Ultragenyx uses at least 1 format(s):
Ultragenyx Email FormatsExamplePercentage
FLast@ultragenyx.comJDoe@ultragenyx.com
95%
FiLast@ultragenyx.comJoDoe@ultragenyx.com
3%
LFirst@ultragenyx.comDJohn@ultragenyx.com
1%
FirstLast@ultragenyx.comJohnDoe@ultragenyx.com
1%

Frequently Asked Questions

Where is Ultragenyx's headquarters located?

Minus sign iconPlus sign icon
Ultragenyx's main headquarters is located at 60 Leveroni Ct Novato, California 94949 US. The company has employees across 5 continents, including North AmericaSouth AmericaEurope.

What is Ultragenyx's phone number?

Minus sign iconPlus sign icon
You can contact Ultragenyx's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Ultragenyx's stock symbol?

Minus sign iconPlus sign icon
Ultragenyx is a publicly traded company; the company's stock symbol is RARE.

What is Ultragenyx's official website and social media links?

Minus sign iconPlus sign icon
Ultragenyx's official website is ultragenyx.com and has social profiles on LinkedIn.

How much revenue does Ultragenyx generate?

Minus sign iconPlus sign icon
As of September 2024, Ultragenyx's annual revenue reached $750M.

What is Ultragenyx's SIC code NAICS code?

Minus sign iconPlus sign icon
Ultragenyx's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Ultragenyx have currently?

Minus sign iconPlus sign icon
As of September 2024, Ultragenyx has approximately 1.5K employees across 5 continents, including North AmericaSouth AmericaEurope. Key team members include Chief Financial Officer And Executive Vice President, Corporate Strategy: H. H.Chief Business Officer: T. K.Chief Medical Officer And Executive Vice President: E. C.. Explore Ultragenyx's employee directory with LeadIQ.

What industry does Ultragenyx belong to?

Minus sign iconPlus sign icon
Ultragenyx operates in the Biotechnology Research industry.

What technology does Ultragenyx use?

Minus sign iconPlus sign icon
Ultragenyx's tech stack includes AtlassianPower BIAutoCadUnpkgFont AwesomeWillis Towers WatsonJuniper NetworksWindows Server.

What is Ultragenyx's email format?

Minus sign iconPlus sign icon
Ultragenyx's email format typically follows the pattern of . Find more Ultragenyx email formats with LeadIQ.

When was Ultragenyx founded?

Minus sign iconPlus sign icon
Ultragenyx was founded in 2010.
Ultragenyx

Ultragenyx

Biotechnology ResearchCalifornia, United States1001-5000 Employees

Leading with purpose. Every day.

“Ultragenyx was founded to advance innovative medicines for rare and ultrarare diseases that have never been treated before. We are delivering transformative therapies across multiple indications, and we have one of the most robust and diverse clinical pipelines in rare disease. Our focus is on doing the right things for patients both during development and commercialization to deliver on the promise of these therapies in a way that's meaningful for rare disease communities.”

Emil D. Kakkis, M.D., Ph.D.
Chief Executive Officer and President


We have an inclusive culture of value and respect.

Ultragenyx brings novel products to those living with rare and ultrarare diseases with a focus on debilitating genetic diseases. Founded in 2010, we have rapidly built a diverse portfolio of approved therapies and products aimed at diseases with a high unmet medical need for which many have no approved therapies. It takes courage, care, talent, and dedication to make a meaningful impact for those living with rare diseases, their families and the rare disease community.  

We put our people first, so they can take care of the rare disease community.

We purposefully cultivate and nurture a dynamic, supportive work environment where we encourage every team member to share their new ideas and help us unlock more possibilities. Our team is made up of exceptional and diverse people with a strong passion and commitment to helping those living with rare diseases. By embracing generosity, curiosity, inclusion, and humility we are constantly learning together—fostering an environment that supports profound growth and fulfillment.

If you want to have a meaningful impact, do the best work of your career while having fun and growing professionally and personally, come join our team!


Visit our community guidelines at: https://ultragenyx.co/community

Section iconCompany Overview

Headquarters
60 Leveroni Ct Novato, California 94949 US
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
RARE
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2010
Employees
1001-5000

Section iconFunding & Financials

  • $100M$1B

    Ultragenyx's revenue is in the range of $100M$1B

Section iconFunding & Financials

  • $100M$1B

    Ultragenyx's revenue is in the range of $100M$1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.